This is a Validated Antibody Database (VAD) review about chimpanzee PATR-DRA, based on 98 published articles (read how Labome selects the articles), using PATR-DRA antibody in all methods. It is aimed to help Labome visitors find the most suited PATR-DRA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PATR-DRA synonym: Patt-Dra

BioLegend
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3a
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3a). elife (2020) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1b
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1b). J Immunother Cancer (2020) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2e
BioLegend PATR-DRA antibody (BioLegend, 307638) was used in flow cytometry on human samples (fig 2e). Cell (2020) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1c
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s1c). BMC Cancer (2020) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 3:50; loading ...; fig 1c
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:100; loading ...; fig s20c
BioLegend PATR-DRA antibody (Biolegend, 307642) was used in flow cytometry on human samples at 1:100 (fig s20c). Nat Commun (2020) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; 0.5 mg/ml; loading ...; fig s11a
BioLegend PATR-DRA antibody (Biolegend, L243) was used in mass cytometry on human samples at 0.5 mg/ml (fig s11a). Nature (2020) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s20
BioLegend PATR-DRA antibody (Biolegend, 307640) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 6b
BioLegend PATR-DRA antibody (Biolegend, 307640) was used in flow cytometry on human samples (fig 6b). Cell Rep (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 7a
BioLegend PATR-DRA antibody (BioLegend, 307629) was used in flow cytometry on human samples (fig 7a). J Exp Med (2020) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s6c
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:50; loading ...; fig e4f
BioLegend PATR-DRA antibody (Biolegend, 307619) was used in flow cytometry on human samples at 1:50 (fig e4f). Nature (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples . JCI Insight (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2d
BioLegend PATR-DRA antibody (Biolegend, 307642) was used in flow cytometry on human samples (fig 2d). Immunity (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s2d
BioLegend PATR-DRA antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig s2d). Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 8a
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 8a). elife (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1b
BioLegend PATR-DRA antibody (Biolegend, 307626) was used in flow cytometry on human samples (fig 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 6
BioLegend PATR-DRA antibody (BioLegend, 307603) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (L243)
  • other; human; loading ...; fig 4b
BioLegend PATR-DRA antibody (BioLegend, 307659) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1). JCI Insight (2019) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig s1
BioLegend PATR-DRA antibody (BioLegend, L243) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1b
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig 2b
BioLegend PATR-DRA antibody (Biolegend, 307602) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:100; loading ...; fig s1c, s3a
BioLegend PATR-DRA antibody (Biolegend, 307650) was used in flow cytometry on human samples at 1:100 (fig s1c, s3a). Cancer Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 2 ug/ml; loading ...; fig s13
BioLegend PATR-DRA antibody (BioLegend, 307623) was used in flow cytometry on human samples at 2 ug/ml (fig s13). Science (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3a
BioLegend PATR-DRA antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:1; fig 5a
BioLegend PATR-DRA antibody (BioLegend, 307610) was used in flow cytometry on human samples at 1:1 (fig 5a). Nat Commun (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:200; loading ...; fig 1b
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:200 (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s3k
BioLegend PATR-DRA antibody (Biolegend, 307618) was used in flow cytometry on human samples (fig s3k). Cell Rep (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 3b). J Clin Invest (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 4a
BioLegend PATR-DRA antibody (BioLegend, 307618) was used in flow cytometry on human samples (fig 4a). J Exp Med (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1c
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1c). J Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend PATR-DRA antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s2d
BioLegend PATR-DRA antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s3b
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3b). J Exp Med (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend PATR-DRA antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend PATR-DRA antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). Nucleic Acids Res (2018) ncbi
mouse monoclonal (L243)
  • blocking or activating experiments; human; loading ...; fig s2b
BioLegend PATR-DRA antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig s2b). Nat Med (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 4a
BioLegend PATR-DRA antibody (BioLegend, H243) was used in flow cytometry on human samples (fig 4a). Int J Infect Dis (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1b
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1b). JCI Insight (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3b
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3b). Oncol Lett (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 1a
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). J Exp Med (2018) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend PATR-DRA antibody (BioLegend, L243) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:50; loading ...
In order to define the transcriptional network specifies conferring microglia identity, BioLegend PATR-DRA antibody (BioLegend, 307616) was used in flow cytometry on human samples at 1:50. Science (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl s3
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend PATR-DRA antibody (biolegend, L243) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig 1h
  • flow cytometry; human
In order to map the lineage of human dendritic cells, BioLegend PATR-DRA antibody (Biolegend, L243) was used in mass cytometry on human samples (fig 1h) and in flow cytometry on human samples . Science (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s6a
In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). MBio (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2e
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2e). Oncoimmunology (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:200; loading ...; fig s1d
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples at 1:200 (fig s1d). Nat Commun (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2b
In order to analyze B-cell responses to meningococcal polysaccharide and conjugate vaccines against Neisseria meningitidis, BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). Genome Med (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; mouse; loading ...; fig 2d
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; rhesus macaque; loading ...; fig 7a
In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on rhesus macaque samples (fig 7a). J Virol (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3b
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2a
BioLegend PATR-DRA antibody (BioLegend, 307606) was used in flow cytometry on human samples (fig 2a). Oncogene (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; mouse; loading ...; fig 1c
In order to test if Mincle signaling drives intrahepatic inflammation and liver injury in Con A hepatitis, BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl 2
In order to identify peanut proteins that can predict peanut allergy., BioLegend PATR-DRA antibody (Biolegend, 307624) was used in flow cytometry on human samples (tbl 2). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2b
In order to elucidate the mechanisms by which DRibbles induce T-cell activation, BioLegend PATR-DRA antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 2b). Cell Death Dis (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 6a
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2b
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). PLoS ONE (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 7a
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 7a). J Biol Chem (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s3
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Am J Transplant (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig s1c
  • immunocytochemistry; human
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1c) and in immunocytochemistry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:200; loading ...; fig s1a
In order to find that central nervous system infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic amyotrophic lateral sclerosis mouse model, BioLegend PATR-DRA antibody (Biolegend, 307616) was used in flow cytometry on human samples at 1:200 (fig s1a). Acta Neuropathol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig s6a
In order to test if AML patients treated decitabine have induced expression of cancer testis antigens, BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). Oncotarget (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:20; fig 2
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:20 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (L243)
  • other; human; loading ...; fig st1
  • flow cytometry; human; loading ...; fig st3
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BioLegend PATR-DRA antibody (BioLegend, L243) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BioLegend PATR-DRA antibody (BioLegend, 307610) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1b
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 1
BioLegend PATR-DRA antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend PATR-DRA antibody (Biolegend, 307604) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 2a
In order to investigate the effect of thymosin on HL-60 cell maturation, BioLegend PATR-DRA antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; tbl s1
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 9a
In order to explore a macrophage TLR9-BTK-calcineurin-NFAT signaling pathway involved in impair fungal immunity, BioLegend PATR-DRA antibody (Biolegend, 307617) was used in flow cytometry on human samples (fig 9a). EMBO Mol Med (2015) ncbi
mouse monoclonal (L243)
  • blocking or activating experiments; human; 15 ug/ml; fig 4
BioLegend PATR-DRA antibody (BioLegend, L432) was used in blocking or activating experiments on human samples at 15 ug/ml (fig 4). Vaccine (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend PATR-DRA antibody (BioLegend, clone L243) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 3
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Nephrol Dial Transplant (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend PATR-DRA antibody (BioLegend, L243) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 1
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend PATR-DRA antibody (Biolegend, 307604) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 6b
BioLegend PATR-DRA antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 6b). J Immunol (2014) ncbi
mouse monoclonal (L243)
In order to investigate the progression of innate responses to mycobacteria in infants, BioLegend PATR-DRA antibody (Biolegend, L243) was used . J Immunol (2014) ncbi
mouse monoclonal (L243)
  • blocking or activating experiments; human; loading ...; fig 5A
In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, BioLegend PATR-DRA antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig 5A). J Immunol (2014) ncbi
Articles Reviewed
  1. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
  2. Stary V, Wolf B, Unterleuthner D, List J, Talic M, Laengle J, et al. Short-course radiotherapy promotes pro-inflammatory macrophages via extracellular vesicles in human rectal cancer. J Immunother Cancer. 2020;8: pubmed publisher
  3. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  4. Morrissey M, Byrne R, Nulty C, McCabe N, Lynam Lennon N, Butler C, et al. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation. BMC Cancer. 2020;20:566 pubmed publisher
  5. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  6. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  7. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
  8. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
  9. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  10. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
  11. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  12. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed publisher
  13. Merola J, Reschke M, Pierce R, Qin L, Spindler S, Baltazar T, et al. Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression. JCI Insight. 2019;4: pubmed publisher
  14. Dutertre C, Becht E, Irac S, Khalilnezhad A, Narang V, Khalilnezhad S, et al. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. Immunity. 2019;51:573-589.e8 pubmed publisher
  15. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
  16. Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed publisher
  17. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  18. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  19. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  20. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed publisher
  21. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  22. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed publisher
  23. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed publisher
  24. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  25. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  26. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  27. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  28. Jin Y, Roberts G, Ferrara T, Ben S, van Geel N, Wolkerstorfer A, et al. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun. 2019;10:391 pubmed publisher
  29. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  30. Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed publisher
  31. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  32. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed publisher
  33. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  34. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  35. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  36. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  37. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  38. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  39. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  40. Dumbovic G, Biayna J, Banús J, Samuelsson J, Roth A, Diederichs S, et al. A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer. Nucleic Acids Res. 2018;46:5504-5524 pubmed publisher
  41. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  42. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
  43. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  44. Liu R, Merola J, Manes T, Qin L, Tietjen G, Lopez Giraldez F, et al. Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. JCI Insight. 2018;3: pubmed publisher
  45. Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines. Oncol Lett. 2018;15:509-514 pubmed publisher
  46. Bujko A, Atlasy N, Landsverk O, Richter L, Yaqub S, Horneland R, et al. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J Exp Med. 2018;215:441-458 pubmed publisher
  47. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  48. Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed publisher
  49. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed publisher
  50. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  51. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed publisher
  52. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  53. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  54. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
  55. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed publisher
  56. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  57. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
  58. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  59. Misra S, Selvam A, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, et al. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. 2016;7:74686-74700 pubmed publisher
  60. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  61. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  62. Greco S, Torres Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, et al. Mincle Signaling Promotes Con A Hepatitis. J Immunol. 2016;197:2816-27 pubmed publisher
  63. van Erp F, Knol E, Pontoppidan B, Meijer Y, van der Ent C, Knulst A. The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children. J Allergy Clin Immunol. 2017;139:358-360.e8 pubmed publisher
  64. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed publisher
  65. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
  66. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  67. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed publisher
  68. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  69. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed publisher
  70. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
  71. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  72. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  73. Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed publisher
  74. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Blagitko Dorfs N, et al. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget. 2016;7:12840-56 pubmed publisher
  75. Johnson D, Estrada M, Salgado R, Sanchez V, Doxie D, Opalenik S, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016;7:10582 pubmed publisher
  76. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  77. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  78. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  79. McCausland M, Juchnowski S, Zidar D, Kuritzkes D, Andrade A, Sieg S, et al. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 2015;10:e0139474 pubmed publisher
  80. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed publisher
  81. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  82. Li X, Liu X, Zhao Y, Zhong R, Song A, Sun L. Effect of thymosin α₁ on the phenotypic and functional maturation of dendritic cells from children with acute lymphoblastic leukemia. Mol Med Rep. 2015;12:6093-7 pubmed publisher
  83. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  84. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  85. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  86. Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240-58 pubmed publisher
  87. Tomimaru Y, Mishra S, Safran H, Charpentier K, Martin W, De Groot A, et al. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Vaccine. 2015;33:1256-66 pubmed publisher
  88. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  89. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  90. Rogacev K, Zawada A, Hundsdorfer J, Achenbach M, Held G, Fliser D, et al. Immunosuppression and monocyte subsets. Nephrol Dial Transplant. 2015;30:143-53 pubmed publisher
  91. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
  92. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed publisher
  93. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed publisher
  94. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  95. Klinker M, Lizzio V, Reed T, Fox D, Lundy S. Human B Cell-Derived Lymphoblastoid Cell Lines Constitutively Produce Fas Ligand and Secrete MHCII(+)FasL(+) Killer Exosomes. Front Immunol. 2014;5:144 pubmed publisher
  96. Fredriksson K, Mishra A, Lam J, Mushaben E, Cuento R, Meyer K, et al. The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses. J Immunol. 2014;192:4497-509 pubmed publisher
  97. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed publisher
  98. Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014;192:940-7 pubmed publisher